Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl

J Chemother. 2017 Feb;29(1):42-44. doi: 10.1179/1973947815Y.0000000009. Epub 2016 May 24.

Abstract

This case report indicates the usefulness of voriconazole for the treatment of central nervous system (CNS) aspergillosis, also in paediatrics. However, it also confirms the need for therapeutic drug monitoring (TDM), especially in younger children that may require very high dosages in order to achieve plasma and cerebrospinal fluid (CSF) therapeutic concentrations.

Keywords: Cerebral aspergillosis; Cerebrospinal fluid concentrations; Children; Leukaemia; Voriconazole.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / cerebrospinal fluid
  • Antineoplastic Agents / therapeutic use
  • Female
  • Humans
  • Immunocompromised Host
  • Infant
  • Neuroaspergillosis / drug therapy*
  • Neuroaspergillosis / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Voriconazole / administration & dosage*
  • Voriconazole / cerebrospinal fluid

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Voriconazole